Bypassing immune rejection in stem cell-based therapies
In an article featured in the latest issue of STEM CELLS, a research group from Stanford University describes a novel regimen for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research Archive
Family history of diabetes increases the risk of prediabetes by 26 per cent
A study involving more than 8,000 participants has shown that people with a family history of diabetes see their risk of…
Clinical trials in India in a crisis: Does it matter?
Dr Prem Pais, Head, Division of Clinical Research and Training, St John’s Research Institute, Bangalore, makes a powerful case for…
Cheaper anti-cancer drug effective in treating most common cause of blindness in older adults
Two drug treatments Lucentis and Avastin are equally effective in treating neovascular or wet age-related macular degeneration
’Our products are safe for juvenile diabetics as well as pregnant, lactating and nursing…
Recently, DSK Nutrition Research Centre has launched two new products for diabetes which do not contain any artificial sweeteners.…
Shorter and cheaper drug trials in pipeline with new research
Chicago Booth professor suggests adaptive model that could save lives with quicker results
Hepatitis B virus control, identifying proteins in mutation management
Researchers at Kanazawa University Graduate School of Medical Science used an avian counterpart for HBV duck HBV (DHBV) to…
Genetic testing of breast cancer: The widening horizon
A bird’s eye view of breast cancer prevalence, diagnosis and the role of BRCA1 and BRCA2 gene testing, from Dr Faisal Khan, Sr…
Playing by protocol
Designing and maintaining a protocol is one of the most challenging aspects of any clinical trial. Sachin Jagdale analyses
Novartis receives positive opinion from CHMP for Lucentis
Lucentis recommended for approval in EU to treat patients with visual impairment due to choroidal neovascularization secondary to…